Cryoablation efficacious for cancer pain, review finds

Cryoablation efficacious for cancer pain, review finds

(HealthDay)—Cryoablation is effective for controlling cancer pain without many side effects, according to a review published online May 7 in PAIN Practice.

Laura Ferrer-Mileo, from L'Hospitalet de Llobregat in Barcelona, Spain, and colleagues conducted a systematic literature review to identify articles that evaluated the efficacy of to control cancer .

Based on 22 included studies (496 patients), the researchers found that cryoablation decreased mean pain scores by 62.5 percent at 24 hours post-cryoablation, by 70 percent at three months, and by 80.9 percent at six months. Relatedly, cryoablation was associated with a 44.2 percent improvement in quality of life after four weeks and a 59.6 percent improvement after eight weeks. At 24 hours, the need for opioids decreased by 75 percent, and by 61.7 percent at three months. The combination of cryoablation with radiotherapy, vertebroplasty, or bisphosphonates appears to be better than cryoablation alone. No fatal complications were reported in any of the studies.

"International criteria are needed to standardize measures used to evaluate pain and over time," the authors write.

More information: Abstract/Full Text (subscription or payment may be required)

Copyright © 2018 HealthDay. All rights reserved.

Citation: Cryoablation efficacious for cancer pain, review finds (2018, May 23) retrieved 3 March 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Icy therapy spot treats cancer in the lung


Feedback to editors